Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2021-05-14 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
110年第1季海外子公司投資
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data related to investments in overseas subsidiaries, including investment amounts, shareholding percentages, and recognized investment gains or losses for a specific quarter (110年1季, which corresponds to Q1 of the year 110 in the Taiwanese calendar). The content is tabular and quantitative, showing actual financial figures rather than just an announcement or summary. The document length is short (896 characters), but it contains substantive financial data for a quarterly period. This matches the definition of an Interim / Quarterly Report (IR), which must contain actual financial statements or substantive financial data and analysis for a period shorter than a full fiscal year. There is no indication that this is merely an announcement or a certification, so it is not RPA or RNS. Therefore, the best classification is IR (Interim / Quarterly Report). Q1 2021
2021-05-14 Chinese
110年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by the company 生達. It includes specific financial figures, investment methods, and regulatory limits, which are typical of a regulatory compliance disclosure rather than a full financial report. The document length is short (1411 characters), and it does not contain comprehensive financial statements or management discussion. It appears to be a regulatory filing related to investment disclosures, likely submitted to a regulatory body for compliance purposes. There is no indication that this is an annual or interim report, audit report, or earnings release. It is not a report publication announcement since it contains substantive data. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-05-14 Chinese
110年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, supervisors, and executives, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, which is characteristic of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document length is sufficient to be a full report rather than a brief announcement. Therefore, the document is best classified as a Director's Dealing report.
2021-05-10 Chinese
110年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It lists their current holdings, pledged shares, and related parties' holdings. The document is titled with the company name and appears to be a disclosure of insider shareholdings and pledges. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The content matches the description of a Director's Dealing report, which involves reporting personal share transactions or holdings by company directors and executives. The document length is short (2394 characters), but it contains substantive data about insider holdings rather than just an announcement. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-05-10 Chinese
110年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company providing details about fund loans and endorsement guarantees for the current and previous months, including amounts and limits. It is a short report (617 characters) with tabular financial data but does not contain comprehensive financial statements or analysis typical of an annual or interim report. It appears to be a regulatory disclosure of financial information related to guarantees and loans, which is common in regulatory filings for transparency but not a full financial report. There is no indication of it being an announcement of a report publication or a certification. Therefore, the best fit is Regulatory Filings (RNS), which covers miscellaneous regulatory disclosures that do not fit other categories.
2021-05-10 Chinese
110年4月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a revenue summary report for a company named 生達, showing monthly and cumulative net operating revenue figures with comparisons to the prior year. It includes notes explaining accounting standards and reporting practices under IFRS. The document length is short (770 characters) and it primarily provides financial data for a specific month (April 2021) and cumulative year-to-date figures. There is no indication that this is an announcement of a report publication or a certification. The content is a concise financial summary for a period shorter than a full fiscal year, containing actual financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-05-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.